Protalix BioTherapeutics, Inc. Long-Term Debt
Protalix BioTherapeutics, Inc. (PLX) had Long-Term Debt of $912.00 thousand as of 2014-12-31, per its 10-Q filed 2015-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2015-11-09
- 2014-12-31: Long-term Debt, Excluding Current Maturities $912.00K.
- 2013-12-31: Long-term Debt, Excluding Current Maturities $2.37M.
- 2013-06-30: Long-term Debt, Excluding Current Maturities $376.00K.
- 2013-03-31: Long-term Debt, Excluding Current Maturities $2.70M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2014-12-31 | $912.00K 10-Q · filed 2015-11-09 |
| 2013-12-31 | $2.37M 10-K · filed 2015-03-12 |
| 2013-06-30 | $376.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $2.70M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $5.42M 10-K · filed 2014-03-13 |
| 2012-09-30 | $2.79M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $4.68M 10-Q · filed 2012-08-03 |
| 2011-12-31 | $6.57M 10-K · filed 2013-02-28 |
| 2011-09-30 | $4.74M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $4.45M 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |